Weiss Multi Strategy Advisers LLC Tg Therapeutics, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

  • $0
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$6.68 - $18.81 $117,815 - $331,751
17,637 Added 41.63%
60,000 $1.03 Million
Q3 2023

Nov 14, 2023
BUY
$8.36 - $26.5 $354,154 - $1.12 Million
42,363 New
42,363 $354,000
Q1 2022

May 16, 2022
SELL
$7.81 - $20.45 $98,921 - $259,019
-12,666 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$15.2 - $35.51 $760 - $1,775
-50 Reduced 0.39%
12,666 $241,000
Q3 2021

Nov 15, 2021
BUY
$21.78 - $40.45 $276,954 - $514,362
12,716 New
12,716 $423,000

Others Institutions Holding TGTX

# of Institutions
287
Shares Held
91.8M
Call Options Held
1.9M
Put Options Held
1.45M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $3.46B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email